NextCell Pharma AB (NXTCL) — Strategic Asset Allocation Index
NextCell Pharma AB (NXTCL) has a Strategic Asset Allocation Index of 11.8% as of February 2023. Strategic assets (PP&E of Skr11.26 Million plus long-term investments of Skr-) total Skr11.26 Million, measured against net assets of Skr95.21 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See NextCell Pharma AB balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
NextCell Pharma AB Strategic Asset Allocation Index (2016–2022)
This chart shows how NextCell Pharma AB's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of February 2023, the index stands at 11.8%, representing strategic assets of Skr11.26 Million against net assets of Skr95.21 Million SEK. For live market cap and overall valuation, see NXTCL company net worth.
Annual Strategic Asset Allocation Index for NextCell Pharma AB (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for NextCell Pharma AB from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See NextCell Pharma AB book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 8.6% | Skr9.90 Million | Skr9.90 Million | Skr- | Skr115.54 Million | ▲ +6.6 pp |
| 2021 | 1.9% | Skr2.90 Million | Skr2.90 Million | Skr- | Skr150.09 Million | ▼ -8.0 pp |
| 2020 | 10.0% | Skr2.61 Million | Skr2.61 Million | Skr- | Skr26.22 Million | ▼ -0.8 pp |
| 2019 | 10.8% | Skr2.48 Million | Skr2.48 Million | Skr- | Skr22.96 Million | ▼ -37.4 pp |
| 2018 | 48.1% | Skr2.43 Million | Skr2.43 Million | Skr- | Skr5.04 Million | ▲ +33.9 pp |
| 2017 | 14.3% | Skr2.73 Million | Skr2.73 Million | Skr- | Skr19.07 Million | ▼ -30.4 pp |
| 2016 | 44.7% | Skr3.02 Million | Skr3.02 Million | Skr- | Skr6.76 Million | — |